Riskpilot← Back to searchSign inGet full access3P Biotech Denmark ApS
APSBankruptCVR 38324659Hvidegårds Ager 63Sewerage · NACE 3700Est. 2017— employees
Revenue 2021
DKK -66K
-13% vs 2020
EBITDA margin
100.0%
+13% vs 2020
Equity ratio
8.0%
Financial strength
Net profit 2021
DKK 392K
+872% vs 2020
| Revenue | DKK -66K | -13% |
| EBITDA | DKK -66K | +13% |
| Net profit | DKK 392K | +872% |
| Total assets | DKK 2,2M | +2% |
| Equity | DKK 175K | +180% |
| Employees | — | — |
Legal name
3P Biotech Denmark ApS
CVR number
38324659
Legal form
Anpartsselskab
NACE code
3700 · Sewerage
Founded
9. januar 2017
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Hvidegårds Ager 63
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | -109 | -39 | -56 | -76 | -66 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -109 | -39 | -56 | -76 | -66 |
| Depreciation & amort. | -0 | -0 | -12 | -50 | -50 |
| EBIT | -109 | -39 | -68 | -126 | -116 |
| Net financials | 0 | -0 | 0 | -0 | 620 |
| Profit before tax | -109 | -39 | -68 | -126 | 504 |
| Tax | -0 | -0 | -0 | -75 | 112 |
| Net profit | -109 | -39 | -68 | -51 | 392 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 12 | 110 | 1.569 | 2.138 | 2.170 |
| Equity | -59 | -99 | -166 | -217 | 175 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 72 | 208 | 1.735 | 2.355 | 1.958 |
| Total debt | 72 | 208 | 1.735 | 2.355 | 1.958 |
EBITDA margin
-6605200.0%
This company
15.8%
Market median
-41805163% vs market
20172021
Equity ratio
8.0%
This company
38.2%
Market median
-79% vs market
20172021
Return on equity
224.4%
This company
18.4%
Market median
+1120% vs market
20172021
Net profit margin
39167700.0%
This company
8.1%
Market median
+483551752% vs market
20172021
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20172021
Debt / equity
11.43×
This company
0.62×
Market median
-1744% vs market
20172021
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-09 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
3B Founder | Founder | 2017 – 2024 |
KE Management | Management | 2017 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Chairman | 2021 – 2022 | |
| Board of Directors | 2017 – 2022 | |
| Chairman | 2017 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50–66.65% | 50–66.65% | 2017 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of 3P Biotech Denmark ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| 3P Biotech Holding AS | Founder | 0 companies |
| Kai Egil Larsen | Management | 0 companies |
| Terje Midtskogen | Chairman | 0 companies |
| Mona Haug Larsen | Board of Directors | 0 companies |
| Terje Midtskogen | Chairman | 0 companies |